Related Experiment Video
Updated: Mar 31, 2026
Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
Published on: May 17, 2024
Annual review of children with neurofibromatosis type 1
B M Dunning-Davies1, A P J Parker1
1Department of Paediatric Neuroscience, Addenbrooke's Hospital, Cambridge, UK.
Insights
This guide helps pediatricians conduct annual reviews for children with neurofibromatosis type 1 (NF1). It focuses on key questions, examinations, investigations, and referrals for effective NF1 management.
Area of Science:
- Pediatric Medicine
- Clinical Genetics
- Neurocutaneous Syndromes
Background:
- Neurofibromatosis type 1 (NF1) is a complex genetic disorder requiring regular monitoring.
- Existing guidelines may not fully address the practicalities of annual reviews for community and acute pediatricians.
- A structured approach is needed to optimize care during routine pediatric assessments for NF1.
Purpose of the Study:
- To establish an evidence-based framework for the annual review of children with NF1.
- To guide pediatricians on essential components of the review, including history, examination, and investigations.
- To clarify referral pathways to tertiary specialists and multidisciplinary teams for comprehensive NF1 management.
Main Methods:
- Review of current evidence and clinical guidelines for neurofibromatosis type 1 management.
- Development of a structured framework for annual pediatric reviews.
- Synthesis of recommendations for screening, investigations, and specialist referrals based on available evidence.
Main Results:
- Provides specific questions for patient history during annual NF1 reviews.
- Outlines key elements for a focused physical examination in children with NF1.
- Offers guidance on timing and indications for further investigations and tertiary referrals.
Conclusions:
- This framework enhances the effectiveness of annual reviews for children with NF1.
- It supports pediatricians in identifying potential complications and ensuring timely specialist input.
- Recommendations address ongoing debates in NF1 screening, particularly for imaging and ophthalmology follow-up.
Abstract:
We aim to provide a concise, evidence-based framework to assist secondary level, community and acute paediatricians during a 20-60 min annual review of children with neurofibromatosis type 1. This review does not cover all aspects of the disorder. We recognise the importance of an overview of the pathogenesis, molecular genetic testing, clinical manifestations and management; we shall cover some of this briefly, but this is not our focus here. We focus instead on the following areas: (A) what questions should be asked during annual review, (B) what should be included in a focused examination, (C) when to request further investigations and (D) when should a referral be made to tertiary specialists and other members of the multidisciplinary team. Ongoing debates regarding screening remain in certain areas, particularly regarding imaging and ophthalmology follow-up; here we summarise the differing opinions and make a recommendation based on the currently available evidence.
